Research and Development

Showing 15 posts of 9612 posts found.

scott_gottlieb

Scott Gottlieb appointed to the FDA’s top role

May 10, 2017 Manufacturing and Production, Research and Development, Sales and Marketing FDA, Scott Gottlieb, Trump

After months of scrutiny, Scott Gottlieb has been confirmed as the new Commissioner of the FDA, following his nomination by …
dr_sonia_quaratino

Kymab instates first Chief Medical Officer

May 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, kymab

Kymab, a therapeutic antibody company based in Cambridge, UK, has announced that it has appointed Dr Sonia Quaratino as its …
dna-1903319_960_720

University of Oxford gains access to biomarker profiling technology

May 9, 2017 Manufacturing and Production, Research and Development Nightingale health, University of Oxford

The University of Oxford has announced that it will benefit from Nightingale Health’s biomarker analysis technology. The Finnish company will …
pills-384846_960_720

£6 million statin study to determine potential therapeutic use in MS

May 9, 2017 Manufacturing and Production, Research and Development multiple sclerosis, statins

A large study will take place in the UK to determine whether statins, commonly prescribed to combat “bad cholesterol”, are …
happy_doctor

Patient reported outcomes: Putting the patient first

May 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

With clinical practice marching towards a more precision-oriented methodology, assessment of treatment efficacy is undergoing a transformation. Matt Fellows explores the …
teva_copy

Teva and Active Biotech hit by Phase 3 drug failure

May 8, 2017 Research and Development, Sales and Marketing Active Biotech, Teva

Teva and Active Biotech have been collaborating on the drug laquinimod since 2004 but it now looks like the work put …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday again, and today marks the press date of the latest edition of Pharmafile, our bi-annual life sciences market …
exit-1722888_960_720

Regulus CEO heads to exit as company struggles with FDA hold

May 5, 2017 Medical Communications, Research and Development Regulus, hepatitis C

Regulus seemed to be in a good place just last year as its lead drug candidate performed well in a …
running-573762_960_720

‘Exercise pill’ boosts endurance by 70% in mice

May 4, 2017 Research and Development

A study by the Salk Institute found that mice that were given a chemical compound, named GW1517 (GW), were able …
world_health_organization_flag

WHO aims to increase uptake of biosimilars in poorer countries

May 4, 2017 Medical Communications, Research and Development Cancer, Roche, WHO, biosimilars

The WHO has announced that it will launch a project to prequalify biosimilar medicines for the treatment of certain cancers. …
blood-1813410_960_720

Cheap blood test may help tailor prostate cancer treatment

May 4, 2017 Research and Development Blood test, prostate cancer

A blood test that costs less than £50 to perform could prevent men from undergoing treatment with two drugs that …
shutterstock_243110086

Real-world data: High on the life science agenda

May 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing real world data, real-world data

John Wise of The Pistoia Alliance discusses the necessity of real-world data for a prosperous future for the life sciences …
shutterstock_159488225

Researchers identify key trigger in melanoma progression

May 3, 2017 Research and Development melanoma

Researchers from life sciences research institute VIB and KU Leuven in Belgium in collaboration with INSERM, the French National Institute …
The Gateway to Local Adoption Series

Latest content